Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Pharmaceutical industry sponsorship of academic conferences

Ethics of conflict of interest

Bibliographic Data

ID21514933
AuthorsSaroj Jayasinghe (0000-0003-1460-6073, University of Colombo, corresponding author)
Year2021
Volume47
Issue12
Pagese33-e33
Publication date2021-12-01
Open AccessNo
TypeARTICLE
VenueJournal of Medical Ethics (JOURNAL)
Journal identifiersISSN: 0306-6800 • E-ISSN: 1473-4257
PublisherBMJ (PUBLISHER • GB)
DOI10.1136/medethics-2020-106224
PMID32703842
OpenAlexW3045338347
LanguageEN
References cited28

Sponsorship of medical conferences by the pharmaceutical industry has led to many ethical issues, especially in resource-poor developing countries. The core issue in these instances is to reduce or avoid conflicts of interests (COIs). COI is a set of circumstances that creates a risk that professional judgment or actions regarding a primary interest will be unduly influenced by secondary interests. Disruption of social trust should also be considered. This deontological approach should be complemented by a consequentialist approach. Towards this, the concept of distal interests (DI ) is introduced. DI lies beyond the immediately visible COIs and the consequences of immediate decisions. They are ‘distal’ in time or place: ‘DI in time’ means consequence of the decision in future scenarios, while ‘DI in space’ means those that impinge on other institutions or bodies. In judging the consequences, it is also necessary to consider the reality of the existing relationship between the pharmaceutical industry and organisers of conferences. In more developed countries, these relationships are governed by stricter regulations, adherence to codes of conduct by both parties and stronger institutional oversights. In contrast, developing countries such as Sri Lanka the regulatory environment is lax and the demarcation of interests between the pharmaceutical industry and the medical profession is considerably blurred. Therefore, establishing clear rules of engagement between the stakeholders should be considered as an attempt to clear the muddy waters. The paper proposes a set of guidelines to capture these approaches

Business · Conflict of interest · Developing country · Economic growth · Economics · Pharmaceutical industry · Political science · Public relations · Sociology · Sri lanka · Computer Science · Ethics in Clinical Research · Law · Medicine · Pharmaceutical Economics and Policy · Pharmaceutical industry and healthcare

  • Raising the Barriers to Access to Medicines in the Developing World – The Relentless Push for Data Exclusivity

    Open Access•Lisa Diependaele, Julian Cockbain et al.•Developing World Bioethics•2017

Highly citedNo

Tools

Open DOI
Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae